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Abstract:  A study of indomethacin release from poly(N-isopropylacrylamide)-graft-
poly(ethylene oxide) PNIPAM-g-PEO vesicular nanoparticles was performed. In vitro 
release studies were conducted in distilled water containing 10% and 20% (v/v) ethanol 
added with different rate and using the dialysis tube method. The nano-sized polymeric 
vesicles were characterized with respect to morphology, drug loading content and in vitro 
drug release kinetics. A mathematical model for indomethacin release, recently proposed by 
the authors, was validated under the obtained experimental results. It was used for numerical 
simulation of indomethacin release from nanoparticles of the considered vesicular type in the 
solution, neglecting the presence of a membrane, within a period of 24 hours. 
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Introduction 
In recent years, polymeric nanoparticles (NPs) with a core-shell structure have attracted much 
attention for their potential application in drug delivery. The small size and stealth properties 
ensure their prolonged blood circulation and access to desired organs and tissues [2]. 
Important advantages of core-shell NPs are high stability and drug-loading capacity, 
feasibility of incorporation of hydrophilic and hydrophobic substances, and feasibility of 
variable routes of administration, including oral application and inhalation [8, 9, 13].  
 
A challenge in the drug targeting is the development of polymeric drug delivery carriers, 
which possess thermally responsive fragments. Among the temperature responsive polymers, 
poly(N-isopropylacrylamide) (PNIPAM) has attracted special interest because it undergoes a 
sharp coil-to-globule transition in water at around 32°C (the lower critical solution 
temperature, LCST) changing from a hydrophilic state below the LCST to a hydrophobic state 
above it [14]. The self-association of PNIPAM copolymers can afford core-shell NPs with 
PNIPAM chains incorporated into either a core or a shell [13]. The formation of core-shell 
structures above the phase transition temperature of double-hydrophilic block copolymers 
consisting of PNIPAM as a thermo sensitive segment and poly(ethylene oxide) (PEO) as 
corona-forming block is well established [5, 11, 15, 16]. The number and distribution of PEO 
grafts, the length of PNIPAM backbone as well as the copolymer concentration have a 
pronounced effect on the performance of such copolymers. The lower copolymer 
concentration and higher degree of PEO grafting lead to the formation of particles smaller in   INT. J. BIOAUTOMATION, 2013, 17(4), 241-248 
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size. Smaller but less dense NPs can be produced by fast heating of dilute solutions of the 
copolymers [5]. This fact is important as the larger free volume inside the PNIPAM core not 
only provides opportunity for efficient loading of larger amounts of compatible drugs but also 
can be a reason for significant acceleration of the drug release rate. 
 
Drug incorporation into PNIPAM-g-PEO NPs has not been reported so far, except for our 
recent study on the self-association behavior of similar copolymers below the LCST, triggered 
by no covalent interactions between PNIPAM and the hydrophobic drug indomethacin (IMC) 
[10]. In the present work, we extend these studies to the formation of   
IMC-loaded PNIPAM-g-PEO vesicular NPs in mixed solutions of ethanol and water. The 
influence of the quantity and addition rate of ethanol on the IMC release are tested using a 
dialysis tube release assembly, which ensures a constant membrane area for the diffusing drug 
molecules. The drug release profiles are analyzed by a recently proposed mathematical model 
[4] considering drug-polymer interactions and dialysis membrane permeability to the tested 
drug. The model is validated by fitting with the obtained experimental results and can be used 
as an effective simulation tool in the design of NPs of the considered vesicular type. 
 
Materials and methods 
Materials 
Preparation and characterization of IMC-loaded PNIPAM-g-PEO vesicular NPs 
PNIPAM-g-PEO vesicular NPs containing IMC were prepared by the nanoprecipitation 
technique [3, 7] at 20°C. In this technique, hydrophobic drugs are dissolved into a water-
miscible organic solvent and the resulting solution is injected into an aqueous solution of a 
copolymer. As the organic solvent diffuses through the dispersing aqueous phase, small 
monodisperse nanostructures are formed as a result of interfacial hydrodynamic phenomena 
[7, 12]. The incorporation of IMC into PNIPAM-g-PEO NPs was performed in mixtures of 
ethanol and water (1:9 and 2:8, v/v) at a drug-to-polymer ratio of 1.5:1 (w/w) according to the 
following procedure. The copolymer was dissolved in water and to this IMC solution in 
ethanol was added either quickly in one shot (fast injected, 0.2 ml·s
−1) or at a slower rate 
(slowly injected, 0.015 ml/s) under moderate magnetic stirring. The obtained clear solution 
having a final polymer concentration of 0.09 mg/ml was allowed to equilibrate for 1 h, then 
filtered through 0.80 μm membrane filter (Sartorius AG, Germany) to remove precipitating 
drug (if any) and the filtrate was immediately analyzed.  
 
IMC loading content was determined by UV-vis spectrometry (Hewlett Packard 8452A) at 
310 nm using the standard method. First, the total IMC concentration was assayed after 
appropriate dilution (25-times) of the filtered sample with ethanol. Then, to obtain the 
quantity of encapsulated drug, the NPs were separated from the aqueous phase by 
ultrafiltration (15 min, 6000 g, Amicon Ultra, 100 000 MWCO) and the amount of dissolved, 
non-encapsulated IMC (the free part) was determined in the resulting filtrate. The IMC 
loading content was calculated from the difference between the total drug concentration in the 
nanoparticle solution and the free part of IMC. 
 
The morphology of PNIPAM-g-PEO vesicular NPs were investigated using HRTEM (high 
resolution transmission electron microscope, JEOL JEM 2100, Japan) operated at   
200 kV. The samples were prepared by placing a drop of the sample solution on a carbon-
coated copper grid followed by drying at room temperature. No staining was used for the 
TEM observations because of the good electron contrast of the tested objects. A TEM image 
of PNIPAM-g-PEO vesicular NPs produced by fact addition of ethanol is presented in Fig. 1. 
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Fig. 1 TEM image of IMC-loaded PNIPAM-g-PEO vesicular NPs  
prepared by fast injection 
 
In vitro IMC release studies were conducted in distilled water containing either 10% or 20% 
(v/v) ethanol using the dialysis tube method [6]. In the release experiment, 5 ml of the 
polymer some solution were transferred into a dialysis tube closed at one end with a dialysis 
membrane (7.065 cm
2 exposed area, MWCO 12  000-14 000, Sigma-Aldrich, Germany).   
The dialysis tube was immersed into an outer vessel containing 100 ml of release medium 
whose ethanol concentration was the same as that of the tested NPs solution. During the 
experiment the temperature of the entire assembly was maintained at 37°C ± 0.5°C, using a 
circulating water jacket (Huber, Germany). At appropriate intervals, 3-ml aliquots were 
withdrawn from the outer aqueous solution and replaced with an equal volume of fresh release 
medium. The released IMC was quantified by UV spectroscopy (Hewlett Packard 8452A) at 
320 nm, using a standard calibration curve. Each release experiment was repeated four times. 
 
Numerical modeling 
The following assumptions for the experimentally observed drug release were accepted [4]: 
(1)  Two main coupled physicochemical processes control IMC release. The first one 
is the release of the bound IMC from the vesicular NPs included in the 
formulation. Diffusion of the free drug from the inner container into the outer 
aqueous phase realizes at the same time;  
(2)  The concentrations of the free drug and the bound one are uniformly distributed in 
the inner container;  
(3) The predominant mechanism of the drug release kinetics from the NPs is 
overcoming the polymer-drug interaction;  
(4)  A perfect sink condition at the boundary from the outer membrane side exists.  
 
The model equation describing the first process is the following [1]:  
 
()
0 3/2
1
() 1
1
bb Mt M
at
⎛⎞
⎜ =−
⎜ + ⎝⎠
⎟
⎟ , (1) 
 
where   and  b M 0 b M  are the current value of the decreasing mass of the bound drug within the 
inner container and its initial value; t is the time. The model parameter a is a rate constant 
referred to overcoming the interaction between the polymer and the embedded drug in the 
NPs.  
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The equation of the diffusion of the free drug mass from the inner container, denoted by  f M , 
is derived on the basis of the Fick’s law and the assumptions (2) and (4) as follows [4]: 
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where 
h
DP
K =  is the permeability constant; D is the drug diffusivity; h is the membrane 
thickness; P is the distribution coefficient.  
 
The total mass of the drug released in the outer tube within a period of t hours is denoted by 
) (t M , referred to the initial total drug mass and the main model equation for fractional drug 
release under zero initial condition is obtained: 
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where   is the initial value of the free drug mass in the solution given from the 
experiment and H is the height of the solution in the inner tube. 
bo o fo M M M − =
 
The following procedure for numerical evaluation of the main model parameters (the drug 
permeability K and the rate parameter a) was proposed: 
 1
st  step. The case of drug pure solution (i.e.  ) in the inner container is 
considered in order to evaluate the permeability K of IMC by fitting the model equations (2) 
to the obtained experimental data. 
o fo M M =
 
 2
nd  step. Evaluation of the rate parameter a  under the determined permeability K 
fitting the model equations (3) to the experimental data for fractional IMC release from 
PNIPAM-g-PEO NPs assembly.  
 
To evaluate the goodness of fit the determination coefficient is calculated at each of the above 
steps, as follows: 
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where   is the arithmetic mean of the experimental data of the considered fractional drug 
release; 
n
arithm R
n
num R  and 
n
exp R , n = 1, …, N are the numerical results and the experimental data 
respectively. 
 
 3
rd step. Numerical simulation of IMC release from the considered NPs following (1) 
under the evaluated value of the model rate parameter a. 
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Numerical results 
The proposed procedure for numerical evaluation of the model parameters was applied under 
37°C for the cases: IMC release in the medium of 10% ethanol of the obtained solution 
prepared by slow and fast injection; IMC release in the medium of 20% ethanol under the 
above conditions. Fitting the model to the experimental data for IMC release from pure 
solution under 10% and 20% ethanol the model parameter K was found as follows:  
 
0.12 = K  cm·h
−1 and   cm·h
−1 ( ).   0.1 = K 0.995
2 = R
 
Finite difference method was applied when evaluating the fractional drug release  ) (t M . 
Standard least square method was used when fitting the model equations with the 
experimental data. 
 
Fig. 2 and Fig. 3 represent the model fitting to experimental data for IMC release from 
PNIPAM-g-PEO NPs assembly under slow and fast injection for 10% and 20% ethanol, 
respectively, when   on average. The obtained values of the model rate parameter a 
are not significantly different (especially for 10% ethanol). It is observed a tendency of drug 
release increase with ethanol content decrease as well as with increase of the rate of injection.  
0.98
2 = R
 
The model parameter a was evaluated under the experimentally measured initial partial free 
drug quantity 
0
0
f M
M
 equal to 13.54%, 8.48%, 25.57% and 12.6% respectively.  
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Fig. 2 Validation of the model for IMC release from NPs at 10% ethanol prepared by: 
(a) slow injection and (b) fast injection 
 
In order to obtain a more reliable picture of IMC release from NPs in the solution we 
performed numerical simulation of the fractional release under evaluated model rate 
parameter a  for each of the cases. It was assumed that the unique process is to overcome the 
interaction between the polymer and the embedded drug in the NPs described by Eq. (1). 
 
In Fig. 4 it is shown the comparison of the model numerical curves of the fractional drug 
release for 10% and 20% ethanol under solution obtained by slow injection as well as for fast 
and slow injection under 20% ethanol. In the other cases significant differences between the 
numerical results were not obtained.   INT. J. BIOAUTOMATION, 2013, 17(4), 241-248 
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Fig. 3 Validation of the model for IMC release from NPs at 20% ethanol prepared by: 
(a) slow injection and (b) fast injection 
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Fig. 4 Simulation of IMC release from NPs in the solution prepared by: 
(a) 10% and 20% ethanol at slow injection and (b) slow and fast injection at 20% ethanol 
 
Conclusion 
A study of the release of the socially important drug IMC from a new type of vesicular NPs 
was performed. 
 
IMC-loaded PNIPAM-g-PEO vesicular NPs were formed in an organic solvent/water system 
as a result of drug-polymer physical interactions. The nano-sized polymeric vesicles were 
characterized with respect to morphology, drug loading content and in vitro drug release 
kinetics.  
 
A mathematical model, recently proposed by the authors [4], was used to continue the study 
of IMC release kinetics from PNIPAM-g-PEO NPs. The experiments for drug release were 
performed in two steps in accordance with the first two steps of the numerical procedure for 
evaluating the model parameters. The first experiment was realized for pure drug solution 
whether the second one – for the NPs solution. The idea of a conditional separation of the   INT. J. BIOAUTOMATION, 2013, 17(4), 241-248 
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main processes enables the consecutive evaluation of the drug permeability and the rate 
constant instead of using more complicated numerical procedures.  
 
The model equations were validated for two different values of ethanol content and two 
different rates of ethanol injection. It was determined a weak tendency of increase of IMC 
release with decrease of ethanol content and increase of the rate of injection. Numerical 
simulation of IMC release from the considered NPs solution was performed for all considered 
cases. Observable differences of IMC release were established for 10% and 20% ethanol 
under slow injection as well as for fast and slow injection under 20% ethanol. 
 
The presented mathematical model and numerical procedure can be used as an effective 
simulation tool in a future study of NPs solutions of the considered type. 
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